Apple is creating a Brain-Computer Interface

Apple, Synchron, backed by Bezos, pioneer brain-computer interfaces with Stentrode implant for device access for mobility issues.

: In a groundbreaking development, Apple has embarked on creating brain-computer interfaces (BCIs) to facilitate device control for individuals with mobility challenges. Their collaboration with Synchron, supported by notable figures like Jeff Bezos and Bill Gates, focuses on applying neural signals for controlling devices such as iPhones and iPads. The Synchron's Stentrode, a less invasive alternative to Neuralink's implants, reads brain signals from above the brain to assist navigation on Apple devices. While currently slower than typical device interaction methods, it's a step towards more accessible technology, with full FDA approval anticipated in the coming years.

Apple is in the process of developing brain-computer interfaces (BCIs) aimed at allowing smoother control over their devices for people facing mobility issues. This initiative particularly targets the enhancement of accessibility for using iPhones, iPads, and Vision Pro headsets. Working alongside Synchron, a company supported by influential investors like Jeff Bezos and Bill Gates, Apple is hoping to revolutionize how neural signals captured by brain implants can inform device control. Synchron's pioneering device, the Stentrode, unlike its competitor Neuralink’s more invasive implants, sits atop the brain rather than inside it, making the procedure less risky for users.

One of the distinguishing features of the Stentrode is its stent-like quality, which allows it to be placed on top of the brain, avoiding the need for open brain surgery. The device reads brain signals through its electrodes and translates them into commands for on-screen navigation and icon selection, working seamlessly with Apple’s existing switch control feature. This innovation allows those with profound physical limitations to experience increased device accessibility.

A key element boosting this development is the high-profile interest and backing from prominent figures in technology and industry. Jeff Bezos and Bill Gates’ support through Synchron indicates a significant push and confidence in this initiative’s potential. While the BCI industry is poised for substantial growth, current benchmarks include Elon Musk's Neuralink, which has implanted devices in three people as of January.

Despite its revolutionary potential, the use of Synchron’s Stentrode does have limitations. Mark Jackson, a resident of Pittsburgh living with ALS, tested the device using Apple’s Vision Pro and noted the lag in interaction speed compared to traditional devices or Neuralink’s devices. The Stentrode's slower speed results from it having fewer electrodes compared to Neuralink’s N1 implant, which affects the volume of brain data it can capture.

Nonetheless, the integration with Apple’s device systems demonstrates a promising future for BCIs. Tom Oxley, CEO and co-founder of Synchron, expressed optimism in Apple’s involvement, highlighting the pioneering step of formalizing brain signals as native input methods alongside traditional touch, voice, and typing options. While adoption is preliminary and awaiting full FDA approval, this partnership marks a significant leap towards embracing brain interfaces as viable tools for accessibility.

Sources: Gizmodo, Wall Street Journal, BusinessWire

TechnologyHardwareinnovation